Why it Matters
Puritan Medical Products is entering federal lobbying for the first time. The swab manufacturer that played a critical role during COVID-19 is now investing in policy influence. This marks a strategic shift for North America’s largest diagnostic products maker.
By the Numbers
- First-time lobbying client: No previous federal lobbying activity
- Lobbying team: 3 lobbyists from ArentFox Schiff LLP
- Team composition: Dan H. Renberg (healthcare veteran), Elizabeth Louise Horner (former Senate counsel), Blake Kaplan Thelander (ex-House staffer)
- Registration date: July 17, 2025
Broader Context
The COVID-19 pandemic exposed vulnerabilities in America’s medical supply chain. Puritan significantly ramped up testing swab production during the crisis. Congressional leaders now emphasize reducing reliance on foreign medical suppliers, particularly China. Domestic manufacturers like Puritan benefit from this “Made in America” push.
The Agenda
Puritan is specifically lobbying on the Public Readiness and Emergency Preparedness Act. Their focus: maintaining liability immunity for medical countermeasures during public health emergencies. This narrow scope suggests targeted defensive lobbying rather than broad policy advocacy.
Competitive Landscape
Puritan joins other medical device companies in Washington lobbying efforts. Masimo Corp. focuses on intellectual property and anti-competitive behavior. Cook Group Inc. and Medtronic Inc. push FDA modernization. The Infectious Diseases Society of America lobbies on Medicare reimbursement – also represented by ArentFox Schiff.
Between The Lines
Congress is actively debating PREP Act protections. The H.R.4388 – PREP Repeal Act and H.R.4668 – End the Vaccine Carveout Act threaten liability protections Puritan wants preserved. Meanwhile, the S.998 – Medical Supply Chain Resiliency Act could benefit domestic manufacturers. A recent House Energy and Commerce hearing titled “Made in America: Strengthening Domestic Manufacturing and Our Health Care Supply Chain” highlighted bipartisan support for domestic production.
The Bottom Line
Puritan’s lobbying debut reflects growing industry recognition that policy shapes business outcomes. The company faces immediate threats to liability protections while positioned to benefit from supply chain nationalism.
All data used in this article came from Legis1. Request a demo to learn more!
Spot something wrong? Report an issue with this article